Abivax S.A.(ABVX)

盘后100.25-0.62-0.61%19:53 EDT

100.87+2.84+2.90%

社区社区
资讯资讯
资料资料
公告公告

- 最新
- 推荐
- 异动解读｜Abivax S.A.盘中下跌5.27%，三期试验癌症病例安全性争议叠加证券欺诈调查持续压制股价
  行情直击 · 06-10 23:01
  异动解读｜Abivax S.A.盘中下跌5.27%，三期试验癌症病例安全性争议叠加证券欺诈调查持续压制股价
- 异动解读｜Abivax S.A.盘中下跌5.32%，三期试验癌症病例安全性争议持续压制股价
  行情直击 · 06-08
  异动解读｜Abivax S.A.盘中下跌5.32%，三期试验癌症病例安全性争议持续压制股价
- 异动解读｜Abivax S.A.盘中下跌5.49%，三期试验癌症病例安全性争议持续压制股价
  行情直击 · 06-05
  异动解读｜Abivax S.A.盘中下跌5.49%，三期试验癌症病例安全性争议持续压制股价
- 异动解读｜Abivax S.A.盘中上涨5.65%，三期试验因癌症病例引发暴跌后延续反弹
  行情直击 · 06-04
  异动解读｜Abivax S.A.盘中上涨5.65%，三期试验因癌症病例引发暴跌后延续反弹
- 异动解读｜Abivax S.A.盘中上涨16.03%，三期试验因癌症病例引发暴跌后盘中延续反弹
  行情直击 · 06-03
  异动解读｜Abivax S.A.盘中上涨16.03%，三期试验因癌症病例引发暴跌后盘中延续反弹
- 异动解读｜Abivax S.A.盘前上涨6.21%，三期试验因癌症病例引发暴跌后盘前延续反弹
  行情直击 · 06-03
  异动解读｜Abivax S.A.盘前上涨6.21%，三期试验因癌症病例引发暴跌后盘前延续反弹
- 异动解读｜Abivax S.A.夜盘上涨5.28%，三期试验因癌症病例引发暴跌后盘后小幅回升
  行情直击 · 06-03
  异动解读｜Abivax S.A.夜盘上涨5.28%，三期试验因癌症病例引发暴跌后盘后小幅回升
- 异动解读｜Abivax S.A.盘后上涨5.12%，三期试验因癌症病例引发暴跌后盘后小幅回升
  行情直击 · 06-03
  异动解读｜Abivax S.A.盘后上涨5.12%，三期试验因癌症病例引发暴跌后盘后小幅回升
- 异动解读｜Abivax S.A.盘中下跌40.7%，三期试验数据因癌症病例复杂化引发市场恐慌
  行情直击 · 06-02
  异动解读｜Abivax S.A.盘中下跌40.7%，三期试验数据因癌症病例复杂化引发市场恐慌
- 异动解读｜Abivax S.A.盘前下跌30.12%，三期试验数据因癌症病例复杂化引发市场恐慌
  行情直击 · 06-02
  异动解读｜Abivax S.A.盘前下跌30.12%，三期试验数据因癌症病例复杂化引发市场恐慌
- 异动解读｜Abivax S.A.夜盘下跌25.58%，Obefazimod三期维持试验达主要终点但市场反应消极
  行情直击 · 06-02
  异动解读｜Abivax S.A.夜盘下跌25.58%，Obefazimod三期维持试验达主要终点但市场反应消极
- 异动解读｜Abivax S.A.盘后上涨31.08%，报170.0美元
  行情直击 · 06-02
  异动解读｜Abivax S.A.盘后上涨31.08%，报170.0美元
- 异动解读｜Abivax S.A.盘中上涨5.03%，财报披露现金储备充裕提振信心
  行情直击 · 05-26
  异动解读｜Abivax S.A.盘中上涨5.03%，财报披露现金储备充裕提振信心
- 异动解读 | 现金储备充裕缓解研发担忧，Abivax S.A.盘前大涨8.26%
  异动解读 · 05-26
  异动解读 | 现金储备充裕缓解研发担忧，Abivax S.A.盘前大涨8.26%
- 异动解读｜Abivax S.A.盘前上涨9.06%，财报披露现金储备充裕提振信心
  行情直击 · 05-26
  异动解读｜Abivax S.A.盘前上涨9.06%，财报披露现金储备充裕提振信心
- 异动解读 | 现金储备充裕缓解研发担忧，Abivax S.A.夜盘大涨9.85%
  异动解读 · 05-26
  异动解读 | 现金储备充裕缓解研发担忧，Abivax S.A.夜盘大涨9.85%
- 异动解读｜Abivax S.A.夜盘上涨5.8%，财报披露现金储备充裕提振信心
  行情直击 · 05-26
  异动解读｜Abivax S.A.夜盘上涨5.8%，财报披露现金储备充裕提振信心
- 异动解读｜Abivax S.A.盘中上涨5.09%，财报发布在即机构看多情绪占优
  行情直击 · 05-22
  异动解读｜Abivax S.A.盘中上涨5.09%，财报发布在即机构看多情绪占优
- 异动解读｜Abivax S.A.盘中上涨5.18%，财报发布在即机构看多情绪占优
  行情直击 · 05-20
  异动解读｜Abivax S.A.盘中上涨5.18%，财报发布在即机构看多情绪占优
- 财报前瞻｜Abivax S.A.本季度营收预计锐减88.78%，机构多头占优
  财报Agent · 05-18
  财报前瞻｜Abivax S.A.本季度营收预计锐减88.78%，机构多头占优
公司概况
公司名称
Abivax S.A.
所属市场
NASDAQ
成立日期
- -
员工人数
- -
办公地址
- -
公司网址
http://www.abivax.com
邮政编码
- -
联系电话
- -
联系传真
- -
公司概况
Abivax Sa是一家于2013年12月4日根据法国法律注册成立。该公司是一家临床阶段的生物技术公司，专注于开发利用人体自然调节机制来稳定慢性炎症性疾病免疫反应的疗法。其主要候选药物obefazimod正处于治疗溃疡性结肠炎的3期开发阶段，并正在开发用于克罗恩病。
- 03-23
  员工持股计划
  Form S-8 - Securities to be offered to employees in employee benefit plans
  Form S-8 - Securities to be offered to employees in employee benefit plans
- 03-23
  年度报告
  Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
  Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
- 01-08
  关联方拟减持公告
  Form 144 - Report of proposed sale of securities
  Form 144 - Report of proposed sale of securities
- 2025-10-28
  关联方拟减持公告
  Form 144 - Report of proposed sale of securities
  Form 144 - Report of proposed sale of securities
- 2025-07-24
  [补充]招股说明书
  Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
  Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
- 2025-07-23
  [补充]招股说明书
  Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
  Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
- 2025-03-24
  员工持股计划
  Form S-8 - Securities to be offered to employees in employee benefit plans
  Form S-8 - Securities to be offered to employees in employee benefit plans
- 2025-03-24
  年度报告
  Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
  Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
- 2024-11-25
  SEC问询函
  Form CORRESP - Correspondence
  Form CORRESP - Correspondence
- 2024-11-14
  超过5%披露
  Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
  Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
- 2024-04-19
  超过5%披露
  Form SC 13G - Statement of acquisition of beneficial ownership by individuals
  Form SC 13G - Statement of acquisition of beneficial ownership by individuals
- 2024-04-05
  年度报告
  Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
  Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
- 2024-02-14
  超过5%披露
  Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
  Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
- 2023-11-23
  超过5%披露
  Form SC 13G - Statement of acquisition of beneficial ownership by individuals
  Form SC 13G - Statement of acquisition of beneficial ownership by individuals
- 2023-10-31
  超过5%披露
  Form SC 13G - Statement of acquisition of beneficial ownership by individuals
  Form SC 13G - Statement of acquisition of beneficial ownership by individuals

分时
5日
日
周
月

数据加载中...

最高

101.48

今开

96.76

量比

0.48

最低

95.87

昨收

98.03

换手率

2.75%

Abivax S.A.(ABVX)

公司概况

热议股票